ArticleBiological procedures online2023

Trastuzumab-resistant breast cancer cells-derived tumor xenograft models exhibit distinct sensitivity to lapatinib treatment in vivo.

Hao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.